Electrophysiological insights into the relationship between calcium dynamics and cardiomyocyte beating function in

Hiroyuki Hamada1,2, Tadashi Tomo3, Sung-Teh Kim4

  • 1Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka-city, Fukuoka, 819-0395, Japan.

Insights

Chronic hemodialysis can cause heart dysfunction by lowering calcium levels. Mathematical modeling revealed that sodium-calcium exchanger (NCX) activity exacerbates this, but NCX inhibitors can prevent cardiomyocyte dysfunction.

Area of Science:

  • Cardiovascular Physiology
  • Nephrology
  • Computational Biology

Background:

  • Chronic hemodialysis with low calcium dialysate can lead to cardiac beating dysfunction in patients.
  • Understanding the impact of calcium dynamics on cardiomyocyte function during hemodialysis is crucial for patient care.

Purpose of the Study:

  • To evaluate the effect of body fluid calcium dynamics during hemodialysis on cardiomyocyte beating using an electrophysiological model.
  • To explore potential preventive measures against hemodialysis-induced cardiomyocyte beating dysfunction.

Main Methods:

  • An electrophysiological mathematical model simulating hemodialysis conditions was employed.
  • Simulations analyzed changes in extracellular and intracellular calcium concentrations and their effects on ion transporter dynamics.
  • The role of the sodium-calcium exchanger (NCX) in cardiomyocyte dysfunction was investigated.

Main Results:

  • Simulated decreases in plasma and interstitial fluid calcium concentrations mirrored clinical observations, causing reduced beating rhythm and contraction force.
  • Reduced interstitial fluid calcium increased NCX inward current, lowering intracellular calcium and weakening cardiomyocyte contraction.
  • Calcium replenishment or NCX inhibition effectively suppressed intracellular calcium decline and stabilized cardiomyocyte function.

Conclusions:

  • Sodium-calcium exchanger (NCX) activity is a key factor in hemodialysis-induced cardiomyocyte beating dysfunction.
  • Therapeutic strategies involving calcium supplementation or NCX inhibition show promise for preventing cardiac complications in hemodialysis patients.
  • Hepatically cleared NCX inhibitors may offer a viable approach to improve the quality of life for patients undergoing chronic hemodialysis.